326-23449-24729
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 853 / AZ
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
-
2021-02-13
Dose 2 — Pfizer-BioNTech
- 2021-02-13
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
- 2021-03-08
-
2021-03-13
Survey response — day 28, dose 2MedDRA: Pyrexia, Swelling, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Had 1st vaccine on 1/23/21 left arm. 2nd vaccine on 2/13/21 in left arm. Afterwards ran fever of 100.4, swelling in left arm and arm pit. Had mammogram on 2/16/21 and got results back 3/11/21 with abnormal results in left breast. Ultra sound next · Healthcare visit (other): Follow up PCP 3/15/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-21
- 2021-03-29
- 2021-05-15
-
2021-08-14
Survey response — 6 months, dose 2MedDRA: Adverse reaction, Ageusia, Anosmia, Breakthrough COVID-19, COVID-19, Cough, Pain, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Allergy symptoms-sneezing, runny nose, body aches, cough, no sense of smell or taste***Delta variant break throughMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-14
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-08-18
-
2021-08-19
Call successfulParticipant prefers to complete VAERS report online
-
2022-02-15
Survey response — 12 months, dose 2MedDRA: Cough, Headache, Pain, Respiratory tract congestion, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stuffy head, sneezing, dry cough, headache and body aches. I have done 2 rapid tests and.both negative. Went yesterday and had a PCR Test and waiting on results.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 5 — day 28, dose 2
Symptoms: Had 1st vaccine on 1/23/21 left arm. 2nd vaccine on 2/13/21 in left arm. Afterwards ran fever of 100.4, swelling in left arm and arm pit. Had mammogram on 2/16/21 and got results back 3/11/21 with abnormal results in left breast. Ultra sound next cut off by CDC
Healthcare visit (other): Follow up PCP 3/15/21
Release 9 — 6 months, dose 2
Symptoms: Allergy symptoms-sneezing, runny nose, body aches, cough, no sense of smell or taste***Delta variant break through
Release 11 — 12 months, dose 2
Symptoms: Stuffy head, sneezing, dry cough, headache and body aches. I have done 2 rapid tests and.both negative. Went yesterday and had a PCR Test and waiting on results.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Adverse reaction | ✓ | · | ✓ |
| SD | Ageusia | ✓ | · | ✓ |
| SD | Anosmia | ✓ | · | ✓ |
| SD | Breakthrough COVID-19 | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SD | Swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release